Parallel nanoliter detection of cancer markers using polymer microchips

Area of Science:

• Biomedical Engineering
• Molecular Diagnostics
• Microfluidics

Background:

• Point-of-care diagnostics require sensitive, rapid, and portable detection systems.
• Microfluidic devices offer miniaturization and high throughput for biological assays.
• Nucleic acid sequence-based amplification (NASBA) is a sensitive method for RNA detection.

Purpose of the Study:

• To develop a general multipurpose microchip technology platform for point-of-care diagnostics.
• To demonstrate the feasibility of real-time NASBA for human papilloma virus (HPV) detection in microchips.
• To evaluate the sensitivity and performance of the microchip system.

Main Methods:

• Development of a cyclic olefin copolymer (COC) microchip with integrated supply and parallel reaction channels.
• Real-time nucleic acid sequence-based amplification (NASBA) for artificial HPV 16 sequences and SiHa cell line samples.
• Simultaneous signal detection in 80 nl volumes across 10 parallel reaction channels.
• Utilizing a custom-made optical detection unit for signal quantification.

Main Results:

• Successful real-time NASBA detection of artificial HPV 16 sequences and SiHa cells in COC microchips.
• Achieved a sensitivity limit of 10(-6) microM for artificial HPV 16 sequences.
• Demonstrated a detection limit of 20 cells/microliter for SiHa cell line samples.
• Performance comparable to conventional readers, indicating clinical potential.

Conclusions:

• The developed microchip platform is suitable for sensitive, real-time molecular diagnostics at the point-of-care.
• Polymer microchips integrated with NASBA enable efficient detection of viral sequences and cell lines.
• This technology holds promise for clinical testing of biological samples, including HPV detection.